Cover Image

RAC‐ing up tumour stemness: Disabled homolog 2 interacting protein and triple‐negative breast cancer

Saved in:

Bibliographic Details
Main Author:	Joe R Delaney (Author)
Format:	Book
Published:	Wiley, 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Interaction of PI3K Inhibition with Homologous Recombination Repair in Triple Negative Breast Cancer Cells
by: Gamze Guney Eskiler
Published: (2019)

Involvement of Wiskott-Aldrich Syndrome Protein Family Verprolin- Homologous Protein (WAVE) and Rac1 in the Phagocytosis of Amyloid- β(1 - 42) in Rat Microglia
by: Yoshihisa Kitamura, et al.
Published: (2003)

Tumour‐suppressive role and clinical application of DAB2IP in triple‐negative breast cancer
by: Yun Yang, et al.
Published: (2023)

Inhibition of the CDK9-cyclin T1 protein-protein interaction as a new approach against triple-negative breast cancer
by: Sha-Sha Cheng, et al.
Published: (2022)

A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer
by: Sambi M, et al.
Published: (2020)

Targeting cancer stem cell plasticity in triple-negative breast cancer
by: Zhengwang Guo, et al.
Published: (2023)

The prognostic value of stem cell markers in triple-negative breast cancer
by: Szintia Almási, et al.
Published: (2023)

Identification of a cytisine-based EED-EZH2 protein-protein interaction inhibitor preventing metastasis in triple-negative breast cancer cells
by: Shasha Cheng, et al.
Published: (2022)

Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42
by: Pelin Kücük, et al.
Published: (2024)

Rhein Derivative 4F Inhibits the Malignant Phenotype of Breast Cancer by Downregulating Rac1 Protein
by: Xinxiao Li, et al.
Published: (2020)

Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell
by: Ranran Liu, et al.
Published: (2023)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017)

Immunotherapy for Triple-Negative Breast Cancer
by: Yifeng Cao, et al.
Published: (2021)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020)

Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells
by: Velázquez-Quesada I, et al.
Published: (2020)

Identification of two cancer stem cell-like populations in triple-negative breast cancer xenografts
by: Jun Nakayama, et al.
Published: (2022)

Cadherins Associate with Distinct Stem Cell-Related Transcription Factors to Coordinate the Maintenance of Stemness in Triple-Negative Breast Cancer
by: Chuanwei Yang, et al.
Published: (2017)

Brain Metastasis in Triple-Negative Breast Cancer
by: Eduarda Bustamante, et al.
Published: (2024)

Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021)

Dr. Elsie Inglis
by: Balfour, Frances, Lady, 1858-1931

Evaluation of molecular effects associated with apoptosis, tumour progression, angiogenesis and metastasis by a novel combination of drugs with ormeloxifene in triple negative breast cancer cells
by: Shehna Sharaf, et al.
Published: (2024)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014)

Neighborhood Social Determinants of Triple Negative Breast Cancer
by: Fokhrul Hossain, et al.
Published: (2019)

Role of flavonoids in inhibiting triple-negative breast cancer
by: Shuai Wang, et al.
Published: (2024)

Oncolytic viruses for triple negative breast cancer and beyond
by: Shengye Jin, et al.
Published: (2021)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
by: Cristina Maccallini, et al.
Published: (2022)

The Roles of DNA Demethylases in Triple-Negative Breast Cancer
by: Shoghag Panjarian, et al.
Published: (2021)

Triple-Negative Lobular Breast Cancer Causing Hydronephrosis
by: Michael Chahin DO, et al.
Published: (2020)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020)

A-maze-ing physics
by: Makhtar, N., et al.
Published: (2022)

Elsie Inglis: The Woman with the Torch
by: McLaren, Eva Shaw; Ashwell, Lena, 1872-1957 [Author of introduction, etc.]

CLIL-ing Your Coursebook
by: David A. Hill
Published: (2009)

Un-"Mask"-ing the leak
by: Karthik V Iyer, et al.
Published: (2020)

C-ing the damage of sepsis
by: Kirsty M. Hooper
Published: (2023)

The Rac inhibitor HV-107 as a potential therapeutic for metastatic breast cancer
by: Grace Velez Crespo, et al.
Published: (2023)

Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer
by: Amy Kwan, et al.
Published: (2022)

Homology modelling and analysis of structure predictions of human tumour necrosis factor ligand superfamily member 8
by: Babatunde Joseph Oso, et al.
Published: (2021)

Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells
by: Yu-Zhu Zhang, et al.
Published: (2021)